Mark Molitch, MD
Enriched profileMartha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University · Northwestern University Feinberg School of Medicine
Mark Molitch is Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University at Northwestern University Feinberg School of Medicine. OpenAlex indexes 634 publications with 37,412 citations (h-index 95); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 20 Oct 2026
Overview
Updated 22 Oct 2026
Mark Molitch, MD, is Martha Leland Sherwin Professor of Endocrinology, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University at Northwestern University Feinberg School of Medicine. The public record shows 634 publications with 37,412 citations (h-index 95), centered on Pituitary Gland Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors, Neuroendocrine Tumor Research Advances. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 11 companies, 4 NIH-funded awards (1986–2018).
- Most recent indexed publication: 2025 · The Journal of clinical endocrinology and metabolism
- Top research focus: Pituitary Gland Disorders and Treatments
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 22 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 287.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 22 Oct 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Use of NPH Versus Basal Bolus Insulin for Steroid Induced Hyperglycemia
Sponsor: Northwestern University
- Study of Glycemic Control on Liver Transplantation Outcomes
Sponsor: Northwestern University
- PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)
Sponsor: Northwestern University
Industry payments
Updated 22 Oct 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Chiesi USA, Inc.Program year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20253 payments
- Corcept TherapeuticsProgram year20252 payments
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
74.8%Insulin Analog63.9%Lantus30%Lantus Solostar24%Humalog17%Humalog Kwikpen U-10015%Novolog Flexpen15%Part D<11 patientsGLP-1 receptor agonist10.9%Victoza 3-Pak100%Part D<11 patientsSensory organs
12.6%Corticosteroid12.6%Hydrocortisone100%Part D<11 patientsHormonal (systemic)
12.6%l-Thyroxine12.6%Levothyroxine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 22 Oct 2026
4 NIH research awards on record, funded 1986–2018 per NIH RePORTER. The latest:
- 10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
Northwestern University at Chicago
FY2018$391,248U01DK048380 - 10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
Northwestern University at Chicago
FY2017$324,075U01DK048380 - 10/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3- Research Project
Northwestern University at Chicago
FY2016$233,941U01DK048380
Congress activity
Updated 22 Oct 2026
22 congress contributions (2011–2024) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 9191 Real-world Biochemical And Symptoms Outcomes With Oral Octreotide: Management Of Acromegaly (MACRO) Registry Experience
ENDO Annual Meeting
ENDO2024Co-author - 420-P: Longitudinal Trajectories of Tubular Biomarkers in Type 1 Diabetes
ADA Scientific Sessions
ADA2023Co-authorPoster - SAT622 Matched Physician- And Patient-reported Responses Of Acromegaly Symptom Control: Comparisons From The Macro Registry
ENDO Annual Meeting
ENDO2023Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 22 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Debate: Surgery as Initial Therapy for Microprolactinoma.
The Journal of clinical endocrinology and metabolism
Editorial2025 - MPOWERED Trial Open-Label Extension: Long-term Efficacy and Safety Data for Oral Octreotide Capsules in Acromegaly.
The Journal of clinical endocrinology and metabolism
Clinical Trial2023
Most-cited works
by citation count (OpenAlex)- 01Acromegaly: An Endocrine Society Clinical Practice GuidelineArticle1,788 citations2014
- 02
- 03
- 04Diabetic Kidney Disease: A Report From an ADA Consensus ConferenceArticle1,149 citations2014
- 05
Network
Updated 22 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 22 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
endocrine.org/podcast/enp67-growth-hormone-deficiency
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 22 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- A.B.
Princeton University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pri-med.com ↗ - M.D.
University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pri-med.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →checkbook.org ↗
- Board Certification in Endocrinology
Diabetes and Metabolism
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →checkbook.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endocrine.org ↗
- Editor
Pituitary journal
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →endocrine.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endocrine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.feinberg.northwestern.edu ↗
Secondary affiliations
appointments beyond the home institution- Center for Diabetes and Metabolism
Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗ - Institute for Public Health and Medicine (IPHAM)
Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
- Robert J. Havey
MD Institute for Global Health (IGH), Northwestern University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →feinberg.northwestern.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Clyde Yancy, MD
Northwestern University Feinberg School of Medicine
Martin Tallman, MD
Northwestern University Feinberg School of Medicine
Al Benson, MD
Northwestern University Feinberg School of Medicine
Sanjiv Shah, MD
Northwestern University Feinberg School of Medicine
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)